(MENAFN- InvestorIdea)
New York N.Y. - February 8 2016 (www.investorideas.com newswire) On Wednesday January 13th Viridian Capital Advisors held its second annual Viridian Cannabis Investor Conference in New York City. Entitled "Investing in the Cannabis Industry While Managing Risk" the event attracted over 200 attendees comprised of family offices private equity funds VC funds high net worth investors corporate executives and members of the media.
Leading companies from key sectors in the cannabis industry presented their businesses and engaged in one-on-one investor sessions at the event including AgTech Real Estate Consumption Devices Infused Products & Extracts Security Software and Biotechnology.
Media coverage of the event included Reuters The Wall Street Journal CNBC VICE Equities.com Black Enterprise and High Times. Reuters produced the following article and video of the event (click the image below to view):
We are capitalizing on the momentum from the success of our New York event by confirming that our next investor event will be held in Miami Florida on March 24 2016 at the prestigious James L. Knight Center in the heart of Downtown Miami.
This will be the first ever cannabis investor conference held in South Florida.
Stay tuned as we will be releasing more information and opening registration for our Miami event soon!
About Viridian Capital Advisors LLC
Viridian Capital Advisors (www.viridianca.com) is a financial and strategic advisory firm dedicated to the cannabis market. We provide market intelligence investment banking investor relations and corporate development services to emerging growth companies in the cannabis sector. Our banking practice through broker-dealer Pickwick Capital Partners provides capital and M&A to fund the growth of our clients while our advisory practice helps to position and build their businesses. Leveraging our team's decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors we provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.
Contact
Bill LivermoreDirector of Corporate Communications(212) 719-2621
More Info:
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news articles and equity research as well as creates original content including video interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution social media and marketing content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspxid=6894. Global investors must adhere to regulations of each country.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.